Metabonomics of human colorectal cancer: New approaches for early diagnosis and biomarker discovery

Journal of Proteome Research

Volumn 13, Issue 9, 2014, Pages 3857-3870

  Ni, Yan ^a,b   Xie, Guoxiang ^a,b   Jia, Wei ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

biomarker discovery; Colorectal cancer; diagnosis; mass spectrometry; metabonomics; NMR spectroscopy; prognosis; translational medicine

Indexed keywords

TUMOR MARKER;

BIOINFORMATICS; BIOMICS; CANCER DIAGNOSIS; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; METABOLITE; METABONOMICS; REVIEW; COLORECTAL NEOPLASMS; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PROCEDURES;

COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; HUMANS; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; TUMOR MARKERS, BIOLOGICAL;

EID: 84914163232     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500443c     Document Type: Review

References (83)

1. Cancer facts & figures 2014; American Cancer Society, Inc: Atlanta, GA.
2. Leddin, D.; Hunt, R.; Champion, M.; Cockeram, A.; Flock, N.; Gould, M.; Kim, Y. I.; Love, J.; Morgan, D.; Natsheh, S.; Sadowski, D.; Ca, C. A. G. Canadian association of gastroenterology and the Canadian digestive health foundation: guidelines on colon cancer screening Can. J. Gastroenterol. 2004, 18, 93-99
3. O'Leary, B. A.; Olynyk, J. K.; Neville, A. M.; Platell, C. F. Cost-effectiveness of colorectal cancer screening: Comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy J. Gastroenterol. Hepatol. 2004, 19, 38-47
4. Rex, D. K.; Johnson, D. A.; Anderson, J. C.; Schoenfeld, P. S.; Burke, C. A.; Inadomi, J. M. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am. J. Gastroenterol. 2009, 104, 739-750
5. LaPointe, L. C.; Pedersen, S. K.; Dunne, R.; Brown, G. S.; Pimlott, L.; Gaur, S.; McEvoy, A.; Thomas, M.; Wattchow, D.; Molloy, P. L.; Young, G. P. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing PLoS One. 2012, 7, e29059
6. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013 Ca-Cancer J. Clin. 2013, 63, 11-30
7. Wang, H. L.; Tso, V. K.; Slupsky, C. M.; Fedorak, R. N. Metabolomics and detection of colorectal cancer in humans: a systematic review Future Oncol. 2010, 6, 1395-1406
8. Huerta, S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer Expert Rev. Mol. Diagn. 2008, 8, 277-288
9. Nicholson, J. K.; Lindon, J. C.; Holmes, E. "Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29, 1181-1189
10. Nicholson, J. K.; Lindon, J. C. Systems biology: metabonomics Nature 2008, 455, 1054-1056
11. Fiehn, O. Metabolomics-the link between genotypes and phenotypes Plant Mol. Biol. 2002, 48, 155-171
12. Yin, P.; Xu, G. Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry Expert Rev. Mol. Diagn. 2013, 13, 339-348
13. Liesenfeld, D. B.; Habermann, N.; Owen, R. W.; Scalbert, A.; Ulrich, C. M. Review of mass spectrometry-based metabolomics in cancer research Cancer Epidemiol., Biomarkers Prev. 2013, 22, 2182-2201
14. Duarte, I. F.; Gil, A. M. Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids Prog. Nucl. Magn. Reson. Spectrosc. 2012, 62, 51-74
15. Serkova, N. J.; Spratlin, J. L.; Eckhardt, S. G. NMR-based metabolomics: translational application and treatment of cancer Curr. Opin. Mol. Ther. 2007, 9, 572-585
16. Williams, M. D.; Reeves, R.; Resar, L. S.; Hill, H. H. Metabolomics of colorectal cancer: past and current analytical platforms Anal. Bioanal. Chem. 2013, 405, 5013-5030
17. Zheng, X. J.; Xie, G. X.; Jia, W. Metabolomic profiling in colorectal cancer: opportunities for personalized medicine Future Med. 2013, 10, 741-755
18. Zhang, A.; Sun, H.; Yan, G.; Wang, P.; Han, Y.; Wang, X. Metabolomics in diagnosis and biomarker discovery of colorectal cancer Cancer Lett. 2014, 345, 17-20
19. Patti, G. J.; Yanes, O.; Siuzdak, G. Metabolomics: the apogee of the omics trilogy Nat. Rev. Mol. Cell Biol. 2012, 13, 263-269
20. Dettmer, K.; Aronov, P. A.; Hammock, B. D. Mass spectrometry-based metabolomics Mass Spectrom. Rev. 2007, 26, 51-78
21. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat. Protoc. 2007, 2, 2692-2703
22. Chan, E. C. Y.; Pasikanti, K. K.; Nicholson, J. K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry Nat. Protoc. 2011, 6, 1483-1499
23. Dunn, W. B.; Broadhurst, D.; Begley, P.; Zelena, E.; Francis-McIntyre, S.; Anderson, N.; Brown, M.; Knowles, J. D.; Halsall, A.; Haselden, J. N.; Nicholls, A. W.; Wilson, I. D.; Kell, D. B.; Goodacre, R.; C, H. S. M. H. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry Nat. Protoc. 2011, 6, 1060-1083
24. Beckonert, O.; Coen, M.; Keun, H. C.; Wang, Y.; Ebbels, T. M.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. High-resolution magic-Angle-spinning NMR spectroscopy for metabolic profiling of intact tissues Nat. Protoc. 2010, 5, 1019-1032
25. Bezabeh, T.; Somorjai, R. L.; Smith, I. C. MR metabolomics of fecal extracts: applications in the study of bowel diseases Magn. Reson. Chem. 2009, 47, S54-S61
26. Wang, T.; Cai, G.; Qiu, Y.; Fei, N.; Zhang, M.; Pang, X.; Jia, W.; Cai, S.; Zhao, L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers ISME J. 2012, 6, 320-329
27. Trifonova, O.; Lokhov, P.; Archakov, A. Postgenomics diagnostics: metabolomics approaches to human blood profiling OMICS: J. Integr. Biol. 2013, 17, 550-559
28. Liu, L. S.; Aa, J. Y.; Wang, G. J.; Yan, B.; Zhang, Y.; Wang, X. W.; Zhao, C. Y.; Cao, B.; Shi, J. A.; Li, M. J.; Zheng, T. A.; Zheng, Y. T.; Hao, G.; Zhou, F.; Sun, J. G.; Wu, Z. M. Differences in metabolite profile between blood plasma and serum Anal. Biochem. 2010, 406, 105-112
29. Walsh, M. C.; Brennan, L.; Malthouse, J. P. G.; Roche, H. M.; Gibney, M. J. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans Am. J. Clin. Nutr. 2006, 84, 531-539
30. Fernandez-Peralbo, M. A.; de Castro, M. D. L. Preparation of urine samples prior to targeted or untargeted metabolomics mass-spectrometry analysis TrAC, Trends Anal. Chem. 2012, 41, 75-85
31. Yin, P. Y.; Xu, G. W. Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry Expert Rev. Mol. Diagn. 2013, 13, 339-348
32. Want, E. J.; Wilson, I. D.; Gika, H.; Theodoridis, G.; Plumb, R. S.; Shockcor, J.; Holmes, E.; Nicholson, J. K. Global metabolic profiling procedures for urine using UPLC-MS Nat. Protoc. 2010, 5, 1005-1018
33. Schenetti, L.; Mucci, A.; Parenti, F.; Cagnoli, R.; Righi, V.; Tosi, M. R.; Tugnoli, V. HR-MAS NMR spectroscopy in the characterization of human tissues: application to healthy gastric mucosa Concepts Magn. Reson., Part A 2006, 28A, 430-443
34. Dunn, W. B.; Ellis, D. I. Metabolomics: current analytical platforms and methodologies TrAC, Trends Anal. Chem. 2005, 24, 285-294
35. Emwas, A. H. M.; Salek, R. M.; Griffin, J. L.; Merzaban, J. NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations Metabolomics. 2013, 9, 1048-1072
36. Chan, E. C. Y.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J. Proteome Res. 2009, 8, 352-361
37. Tessem, M. B.; Selnaes, K. M.; Sjursen, W.; Trano, G.; Giskeodegard, G. F.; Bathen, T. F.; Gribbestad, I. S.; Hofsli, E. Discrimination of patients with microsatellite instability colon cancer using H-1 HR MAS MR spectroscopy and chemometric analysis J. Proteome Res. 2010, 9, 3664-3670
38. Mirnezami, R.; Jimenez, B.; Li, J. V.; Kinross, J. M.; Veselkov, K.; Goldin, R. D.; Holmes, E.; Nicholson, J. K.; Darzi, A. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies Ann. Surg. 2014, 259, 1138-1149
39. Mal, M.; Koh, P. K.; Cheah, P. Y.; Chan, E. C. Y. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry Anal. Bioanal. Chem. 2012, 403, 483-493
40. Lei, Z.; Huhman, D. V.; Sumner, L. W. Mass spectrometry strategies in metabolomics J. Biol. Chem. 2011, 286, 25435-25442
41. Hirayama, A.; Kami, K.; Sugimoto, M.; Sugawara, M.; Toki, N.; Onozuka, H.; Kinoshita, T.; Saito, N.; Ochiai, A.; Tomita, M.; Esumi, H.; Soga, T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry Cancer Res. 2009, 69, 4918-4925
42. Chen, J. L.; Fan, J.; Yan, L. S.; Guo, H. Q.; Xiong, J. J.; Ren, Y.; Hu, J. D. Urine metabolite profiling of human colorectal cancer by capillary electrophoresis mass spectrometry based on MRB Gastroenterol. Res. Pract. 2012, 125890
43. Cheng, Y.; Xie, G. X.; Chen, T. L.; Qiu, Y. P.; Zou, X.; Zheng, M. H.; Tan, B. B.; Feng, B.; Dong, T. T.; He, P. A.; Zhao, L. J.; Zhao, A. H.; Xu, L. X.; Zhang, Y.; Jia, W. Distinct urinary metabolic profile of human colorectal cancer J. Proteome Res. 2012, 11, 1354-1363
44. Tan, B. B.; Qiu, Y. P.; Zou, X.; Chen, T. L.; Xie, G. X.; Cheng, Y.; Dong, T. T.; Zhao, L. J.; Feng, B.; Hu, X. F.; Xu, L. X.; Zhao, A. H.; Zhang, M. H.; Cai, G. X.; Cai, S. J.; Zhou, Z. X.; Zheng, M. H.; Zhang, Y.; Jia, W. Metabonomics identifies serum metabolite markers of colorectal cancer J. Proteome Res. 2013, 12, 3000-3009
45. Ritchie, S. A.; Ahiahonu, P. W. K.; Jayasinghe, D.; Heath, D.; Liu, J.; Lu, Y. S.; Jin, W.; Kavianpour, A.; Yamazaki, Y.; Khan, A. M.; Hossain, M.; Su-Myat, K. K.; Wood, P. L.; Krenitsky, K.; Takemasa, I.; Miyake, M.; Sekimoto, M.; Monden, M.; Matsubara, H.; Nomura, F.; Goodenowe, D. B. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection BMC Med. 2010, 8
46. Tautenhahn, R.; Patti, G. J.; Rinehart, D.; Siuzdak, G. XCMS Online: a web-based platform to process untargeted metabolomic data Anal. Chem. 2012, 84, 5035-5039
47. Katajamaa, M.; Oresic, M. Data processing for mass spectrometry-based metabolomics J. Chromatogr. A 2007, 1158, 318-328
48. Ni, Y.; Qiu, Y.; Jiang, W.; Suttlemyre, K.; Su, M.; Zhang, W.; Jia, W.; Du, X. ADAP-GC 2.0: deconvolution of coeluting metabolites from GC/TOF-MS data for metabolomics studies Anal. Chem. 2012, 84, 6619-6629
49. Liland, K. H. Multivariate methods in metabolomics-from pre-processing to dimension reduction and statistical analysis TrAC, Trends Anal. Chem. 2011, 30, 827-841
50. van den Berg, R. A.; Hoefsloot, H. C. J.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genomics. 2006, 7
51. Goodacre, R.; Broadhurst, D.; Smilde, A. K.; Kristal, B. S.; Baker, J. D.; Beger, R.; Bessant, C.; Connor, S.; Calmani, G.; Craig, A.; Ebbels, T.; Kell, D. B.; Manetti, C.; Newton, J.; Paternostro, G.; Somorjai, R.; Sjostrom, M.; Trygg, J.; Wulfert, F. Proposed minimum reporting standards for data analysis in metabolomics Metabolomics. 2007, 3, 231-241
52. Boccard, J.; Veuthey, J. L.; Rudaz, S. Knowledge discovery in metabolomics: an overview of MS data handling J. Sep. Sci. 2010, 33, 290-304
53. Sugimoto, M.; Kawakami, M.; Robert, M.; Soga, T.; Tomita, M. Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis Curr. Bioinf. 2012, 7, 96-108
54. Creek, D. J.; Dunn, W. B.; Fiehn, O.; Griffin, J. L.; Hall, R. D.; Lei, Z. T.; Mistrik, R.; Neumann, S.; Schymanski, E. L.; Sumner, L. W.; Trengove, R.; Wolfender, J. L. Metabolite identification: are you sure? And how do your peers gauge your confidence? Metabolomics. 2014, 10, 350-353
55. Go, E. P. Database resources in metabolomics: an overview J. Neuroimmune Pharmacol. 2010, 5, 18-30
56. Wishart, D. S.; Jewison, T.; Guo, A. C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; Bouatra, S.; Sinelnikov, I.; Arndt, D.; Xia, J.; Liu, P.; Yallou, F.; Bjorndahl, T.; Perez-Pineiro, R.; Eisner, R.; Allen, F.; Neveu, V.; Greiner, R.; Scalbert, A. HMDB 3.0-the human metabolome database in 2013 Nucleic Acids Res. 2013, 41, D801-D807
57. Smith, C. A.; O'Maille, G.; Want, E. J.; Qin, C.; Trauger, S. A.; Brandon, T. R.; Custodio, D. E.; Abagyan, R.; Siuzdak, G. METLIN: a metabolite mass spectral database Ther. Drug Monit. 2005, 27, 747-751
58. Issaq, H. J.; Waybright, T. J.; Veenstra, T. D. Cancer biomarker discovery: opportunities and pitfalls in analytical methods Electrophoresis 2011, 32, 967-975
59. Qiu, Y. P.; Cai, G. X.; Su, M. M.; Chen, T. L.; Liu, Y. M.; Xu, Y.; Ni, Y.; Zhao, A. H.; Cai, S. J.; Xu, L. X.; Jia, W. Urinary metabonomic study on colorectal cancer J. Proteome Res. 2010, 9, 1627-1634
60. Qiu, Y. P.; Cai, G. X.; Su, M. M.; Chen, T. L.; Zheng, X. J.; Xu, Y.; Ni, Y.; Zhao, A. H.; Xu, L. X.; Cai, S. J.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8, 4844-4850
61. Nishiumi, S.; Kobayashi, T.; Ikeda, A.; Yoshie, T.; Kibi, M.; Izumi, Y.; Okuno, T.; Hayashi, N.; Kawano, S.; Takenawa, T.; Azuma, T.; Yoshida, M. A novel serum metabolomics-based diagnostic approach for colorectal cancer PLoS One 2012, 7, e40459
62. Kondo, Y.; Nishiumi, S.; Shinohara, M.; Hatano, N.; Ikeda, A.; Yoshie, T.; Kobayashi, T.; Shiomi, Y.; Irino, Y.; Takenawa, T.; Azuma, T.; Yoshida, M. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry Biomarkers Med. 2011, 5, 451-460
63. Claudino, W. M.; Goncalves, P. H.; di Leo, A.; Philip, P. A.; Sarkar, F. H. Metabolomics in cancer: a bench-to-bedside intersection Crit. Rev. Oncol. Hematol. 2012, 84, 1-7
64. Farshidfar, F.; Weljie, A. M.; Kopciuk, K.; Buie, W. D.; MacLean, A.; Dixon, E.; Sutherland, F. R.; Molckovsky, A.; Vogel, H. J.; Bathe, O. F. Serum metabolomic profile as a means to distinguish stage of colorectal cancer Genome Med. 2012, 4
65. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "Field-Effects" enables colorectal cancer staging and prognostication J. Proteome Res. 2013, 12, 959-968
66. Qiu, Y.; Cai, G.; Zhou, B.; Li, D.; Zhao, A.; Xie, G.; Li, H.; Cai, S.; Xie, D.; Huang, C.; Ge, W.; Zhou, Z.; Xu, L. X.; Jia, W.; Zheng, S.; Yen, Y.; Jia, W. A distinct metabolic signature of human colorectal cancer with prognostic potential Clin. Cancer Res. 2014, 20, 2136-2146
67. Ma, Y. L.; Qin, H. L.; Liu, W. J.; Peng, J. Y.; Huang, L.; Zhao, X. P.; Cheng, Y. Y. Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer Dig. Dis. Sci. 2009, 54, 2655-2662
68. Bertini, I.; Cacciatore, S.; Jensen, B. V.; Schou, J. V.; Johansen, J. S.; Kruhoffer, M.; Luchinat, C.; Nielsen, D. L.; Turano, P. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer Cancer Res. 2012, 72, 356-364
69. Lindon, J. C.; Nicholson, J. K.; Holmes, E.; Keun, H. C.; Craig, A.; Pearce, J. T.; Bruce, S. J.; Hardy, N.; Sansone, S. A.; Antti, H.; Jonsson, P.; Daykin, C.; Navarange, M.; Beger, R. D.; Verheij, E. R.; Amberg, A.; Baunsgaard, D.; Cantor, G. H.; Lehman-McKeeman, L.; Earll, M.; Wold, S.; Johansson, E.; Haselden, J. N.; Kramer, K.; Thomas, C.; Lindberg, J.; Schuppe-Koistinen, I.; Wilson, I. D.; Reily, M. D.; Robertson, D. G.; Senn, H.; Krotzky, A.; Kochhar, S.; Powell, J.; van der Ouderaa, F.; Plumb, R.; Schaefer, H.; Spraul, M. Summary recommendations for standardization and reporting of metabolic analyses Nat. Biotechnol. 2005, 23, 833-838
70. Ma, Y. L.; Zhang, P.; Wang, F.; Liu, W. J.; Yang, J. J.; Qin, H. L. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer Ann. Surg. 2012, 255, 720-730
71. Ludwig, C.; Ward, D. G.; Martin, A.; Viant, M. R.; Ismail, T.; Johnson, P. J.; Wakelam, M. J. O.; Gunther, U. L. Fast targeted multidimensional NMR metabolomics of colorectal cancer Magn. Reson. Chem. 2009, 47, S68-S73
72. Yue, H.; Wang, Y.; Zhang, Y.; Ren, H.; Wu, J.; Ma, L.; Liu, S. Y. A metabonomics study of colorectal cancer by RRLC-QTOF/MS J. Liq. Chromatogr. Relat. Technol. 2013, 36, 428-438
73. Chen, J. L.; Fan, J.; Yan, L. S.; Guo, H. Q.; Xiong, J. J.; Ren, Y.; Hu, J. D. Urine metabolite profiling of human colorectal cancer by capillary electrophoresis mass spectrometry based on MRB Gastroenterol. Res. Pract. 2012, 2012, 125890
74. Mal, M.; Koh, P. K.; Cheah, P. Y.; Chan, E. C. Y. Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue Rapid Commun. Mass Spectrom. 2009, 23, 487-494
75. Denkert, C.; Budczies, J.; Weichert, W.; Wohlgemuth, G.; Scholz, M.; Kind, T.; Niesporek, S.; Noske, A.; Buckendahl, A.; Dietel, M.; Fiehn, O. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover Mol. Cancer 2008, 7
76. Ong, E. S.; Zou, L.; Li, S.; Cheah, P. Y.; Eu, K. W.; Ong, C. N. Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis Mol. Cell. Proteomics 2010, M900551-MCP200
77. 1H nuclear magnetic resonance spectroscopy Chin. J. Chem. 2011, 29, 2511-2519
78. Righi, V.; Durante, C.; Cocchi, M.; Calabrese, C.; Di Febo, G.; Lecce, F.; Pisi, A.; Tugnoli, V.; Mucci, A.; Schenetti, L. Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses J. Proteome Res. 2009, 8, 1859-1869
79. Piotto, M.; Moussallieh, F. M.; Dillmann, B.; Imperiale, A.; Neuville, A.; Brigand, C.; Bellocq, J. P.; Elbayed, K.; Namer, I. J. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning H-1 magnetic resonance spectroscopy Metabolomics 2009, 5, 292-301
80. 1H HR-MAS NMR spectroscopy Bull. Korean Chem. Soc. 2013, 34, 1467-1472
81. Chae, Y. K.; Kang, W. Y.; Kim, S. H.; Joo, J. E.; Han, J. K.; Hong, B. W. Combining information of common metabolites reveals global differences between colorectal cancerous and normal tissues Bull. Korean Chem. Soc. 2010, 31, 379-383
82. Monleon, D.; Morales, J. M.; Barrasa, A.; Lopez, J. A.; Vazquez, C.; Celda, B. Metabolite profiling of fecal water extracts from human colorectal cancer NMR Biomed. 2009, 22, 342-348
83. Weir, T. L.; Manter, D. K.; Sheflin, A. M.; Barnett, B. A.; Heuberger, A. L.; Ryan, E. P. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults PLoS One 2013, 8, e70803